We tested the applicability of the stress buffering hypothesis in a developing country setting with data from the Senior Sample of the Malaysian Family Life Survey-2. Using ordered logistic regression methods, we examined whether having daily contact with adult children moderates the effect of low socioeconomic status (SES; conceptualized as a chronic stressor) on self-assessed health status. We found that low SES is associated with poorer health for all three ethnic groups--Malay, Chinese, and Indian. Further, for Malays and Chinese, we found that the negative effects of low SES on health tend to be stronger for older people with less frequent contact with adult children than for those who have daily contact. These results provide general support for the buffering model and suggest that, as found in developed countries, active intergenerational relationships in developing country settings may have protective effects on the health of older people experiencing chronic stressors.
To reduce surface contamination and increase battery life, MoO3 nanoparticles were coated with a high-voltage (5 V) LiNi0.5Mn1.5O4 cathode material by in-situ method during the high-temperature annealing process. To avoid charging by more than 5 V, we also developed a system based on anode-limited full-cell with a negative/positive electrode (N/P) ratio of 0.9. The pristine LiNi0.5Mn1.5O4 was initially prepared by high-energy ball-mill with a solid-state reaction, followed by a precipitation reaction with a molybdenum precursor for the MoO3 coating. The typical structural and electrochemical behaviors of the materials were clearly investigated and reported. The results revealed that a sample of 2 wt.% MoO3-coated LiNi0.5Mn1.5O4 electrode exhibited an optimal electrochemical activity, indicating that the MoO3 nanoparticle coating layers considerably enhanced the high-rate charge-discharge profiles and cycle life performance of LiNi0.5Mn1.5O4 with a negligible capacity decay. The 2 wt.% MoO3-coated LiNi0.5Mn1.5O4 electrode could achieve high specific discharge capacities of 131 and 124 mAh g-1 at the rates of 1 and 10 C, respectively. In particular, the 2 wt.% MoO3-coated LiNi0.5Mn1.5O4 electrode retained its specific capacity (87 mAh g-1) of 80.1% after 500 cycles at a rate of 10 C. The Li4Ti5O12/LiNi0.5Mn1.5O4 full cell based on the electrochemical-cell (EL-cell) configuration was successfully assembled and tested, exhibiting excellent cycling retention of 93.4% at a 1 C rate for 100 cycles. The results suggest that the MoO3 nano-coating layer could effectively reduce side reactions at the interface of the LiNi0.5Mn1.5O4 cathode and the electrolyte, thus improving the electrochemical performance of the battery system.
Background: The effectiveness and safety of using Brucea javanica oil (BJO) in combination with Transarterial Chemoembolization (TACE) for liver cancer treatment are subjects of debate. This study aims to assess the comparative effectiveness and safety of BJO-assisted TACE versus TACE alone and quantifies the differences between these two treatment methods. Methods: A systematic search was conducted in multiple databases including PubMed, Cochrane, CNKI, and Wanfang, until 1 July 2023. Meta-analysis was conducted, and the results were presented as mean difference (MD), risk ratio (RR), and 95% confidence intervals (CI). Results: The search yielded 11 RCTs, with a combined sample size of 1054 patients. Meta-analysis revealed that BJO-assisted TACE exhibited superior outcomes compared to standalone TACE. Specific data revealed that BJO-assisted TACE improves clinical benefit rate by 22% [RR = 1.22, 95% CI (1.15, 1.30)], increases the number of people with improved quality of life by 32%, resulting in an average score improvement of 9.53 points [RR = 1.32, 95% CI (1.22, 1.43); MD = 9.53, 95% CI (6.95, 12.10)]. Furthermore, AFP improvement rate improved significantly by approximately 134% [RR = 2.34, 95% CI (1.58, 3.46)], accompanied by notable improvements in liver function indicators, with an average reduction of 27.19 U/L in AST [MD = -27.19, 95% CI (-40.36, -14.02)], 20.77 U/L in ALT [MD = -20.77, 95% CI (-39.46, -2.08)], 12.17 μmol/L in TBIL [MD = -12.17, 95% CI (-19.38, -4.97)], and a decrease of 43.72 pg/mL in VEGF [MD = -43.72, 95% CI (-63.29, -24.15)]. Most importantly, there was a 29% reduction in the occurrence of adverse reactions [RR = 0.71, 95% CI (0.60, 0.84)]. Conclusion: These findings indicate that BJO-assisted TACE may be considered as a potentially beneficial treatment option for liver cancer patients when compared to standalone TACE. It appears to contribute to improved treatment outcomes, enhanced quality of life, and potentially reduced adverse reactions, suggesting it warrants further investigation as a promising approach for liver cancer treatment. Systematic Review Registration: identifier CRD42023428948.